Cyclin-dependent kinase 1–Cyclin D1–Cyclin-dependent kinase 4–Proliferating cell nuclear antigen–E2F transcription factor 1 cell-cycle axis (CDK1–CCND1–CDK4–PCNA–E2F1 axis) (CDK1–CCND1–CDK4–PCNA–E2F1 axis)

The CDK1–CCND1–CDK4–PCNA–E2F1 cell-cycle axis is a fundamental regulatory pathway that governs the transition of eukaryotic cells through the division cycle, particularly the G1 to S phase progression. Cyclin D1 (CCND1) acts as a regulatory subunit that activates Cyclin-dependent kinase 4 (CDK4), which in turn phosphorylates the retinoblastoma protein (Rb), leading to the release of E2F transcription factor 1 (E2F1) (Source: PubMed 2463980). E2F1 then initiates the transcription of genes essential for DNA synthesis and S-phase entry. Proliferating cell nuclear antigen (PCNA) serves as a DNA clamp and scaffold, coordinating DNA replication and repair by interacting with various cell cycle regulators (Source: UniProt P12004). Cyclin-dependent kinase 1 (CDK1) is the primary driver of the G2/M transition but also maintains redundant functions that support G1/S progression (Source: PubMed 17446440). Dysregulation of this axis, such as through CCND1 amplification or loss of CDK inhibitors like p16INK4a, is a hallmark of oncogenesis and leads to uncontrolled cell proliferation (Source: NIH/NCI). Therapeutic targeting of this axis is primarily achieved through CDK4/6 inhibitors like palbociclib and ribociclib, which induce G1 phase arrest in susceptible cancer cells (Source: PubChem CID 5330286).

Other names

CDK-RB-E2F axisG1/S transition pathwayCyclin-CDK-E2F signaling networkCell cycle regulatory axis

Inhibition of cyclin-dependent kinases (CDK1, CDK4) to prevent Rb phosphorylation and E2F1-mediated transcription, leading to G1 or G2/M phase arrest.